Premium
Variability in spinal and supraspinal respiratory motor output in a mouse model of Pompe Disease
Author(s) -
Fuller David D,
Qiu Kai,
Lee KunZe,
Reier Paul J,
Byrne Barry J
Publication year - 2010
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.24.1_supplement.799.18
Subject(s) - respiratory system , control of respiration , brainstem , ventilation (architecture) , glycogen , efferent , respiration , endocrinology , chemistry , anesthesia , medicine , anatomy , afferent , mechanical engineering , engineering
Pompe disease is a lysosomal storage disorder reflecting systemic acid α‐glucosidase (Gaa) deficiency. We recently reported that a murine Pompe model (the Gaa −/− mouse) shows glycogen accumulation in phrenic motoneurons, reduced breathing frequency and an apparent reduction in phrenic burst amplitude (DeRuisseau et al. PNAS, 2009). We hypothesized that alterations in the neural control of breathing in Gaa −/− mice would result in increased breath‐to‐breath variability in the timing and amplitude of efferent spinal (phrenic) and brainstem (hypoglossal, XII) signals. Neurograms recorded in anesthetized, vagotomized, and ventilated mice showed that the coefficient of variation (CV) of inspiratory duration was larger in Gaa −/− vs. B6/129 control mice (P<0.05). The burst amplitude CV for Gaa −/− mice tended to be greater for phrenic (P=0.07) and was greater for XII output (P<0.05). Additional experiments are testing the hypothesis that intraspinal delivery of the Gaa gene via adeno‐associated virus (AAV5‐GAA) mitigates glycogen accumulation and respiratory control deficits in Gaa −/− mice. Immunhistological data obtained 4–8 wks post AAV5‐GAA injection (4–6 0.5 μL injections, 4.5×10 13 vg/ml) indicate Gaa expression in cervical spinal motoneurons and interneurons. We are presently evaluating the impact of the spinal injection on glycogen accumulation and ventilation.